Pain after cesarean section
Conditions
Interventions
Experimental group:Bilateral transverse fascia plane injection of 0.35% (Yichang Renfu Pharmaceutical Co., Ltd.) ropicaine hydrochloride.
Control group:Normal saline
Sponsors
Xiangyang No.1 People's Hospital,Hubei University of Medcine
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1.Patients undergoing cesarean section for singleton pregnancy under elective lumbar anesthesia; 2. Age between 18-45 years old; 3. ASA classification is I-II level.
Exclusion criteria
Exclusion criteria: 1. The patient refused to participate in the study; 2. BMI >= 40 kg.m-2; 3. History of chronic pain, opioid use, or drug abuse; 4. Contraindications or allergies to the experimental drug; 5. There are contraindications for spinal anesthesia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain at rest and on movement;Recorded quality of recovery 24 h and 48 h after block (QoR-15 scores) and participant satisfaction at the same times ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Opioid dose to 24 h after fascia plane injection;Cumulative opioid dose at 6 h, 12 h, 24 h and 48 h after fascia plane injection, and time to first opioid administration;Adverse events;Telephoned participants 30 days and 60 days after surgery and recorded their pain scores at rest and during movement and their QoR-15 scores; | — |
Countries
China
Contacts
Public ContactHaijin Wang
Xiangyang No.1 People's Hospital,Hubei University of Medcine
Outcome results
None listed